Does IRINOTECAN Cause Neoplasm progression? 661 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 661 reports of Neoplasm progression have been filed in association with IRINOTECAN (Irinotecan Hydrochloride). This represents 2.4% of all adverse event reports for IRINOTECAN.
661
Reports of Neoplasm progression with IRINOTECAN
2.4%
of all IRINOTECAN reports
186
Deaths
113
Hospitalizations
How Dangerous Is Neoplasm progression From IRINOTECAN?
Of the 661 reports, 186 (28.1%) resulted in death, 113 (17.1%) required hospitalization, and 33 (5.0%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRINOTECAN. However, 661 reports have been filed with the FAERS database.
What Other Side Effects Does IRINOTECAN Cause?
Diarrhoea (4,157)
Neutropenia (2,533)
Nausea (2,374)
Disease progression (2,018)
Off label use (2,018)
Vomiting (1,944)
Fatigue (1,515)
Febrile neutropenia (1,357)
Anaemia (1,231)
Thrombocytopenia (1,214)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which IRINOTECAN Alternatives Have Lower Neoplasm progression Risk?
IRINOTECAN vs IRON
IRINOTECAN vs IRON DEXTRAN
IRINOTECAN vs IRON ISOMALTOSIDE 1000
IRINOTECAN vs IRON POLYMALTOSE
IRINOTECAN vs IRON SUCROSE